These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 17608681)

  • 1. Serotonin and noradrenaline involvement in urinary incontinence, depression and pain: scientific basis for overlapping clinical efficacy from a single drug, duloxetine.
    Thor KB; Kirby M; Viktrup L
    Int J Clin Pract; 2007 Aug; 61(8):1349-55. PubMed ID: 17608681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Duloxetine--three birds with one stone?
    Michel MC
    Int J Clin Pract; 2007 Aug; 61(8):1247-8. PubMed ID: 17627705
    [No Abstract]   [Full Text] [Related]  

  • 3. Is there a place for duloxetine?
    Drug Ther Bull; 2007 Apr; 45(4):29-32. PubMed ID: 17451072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Duloxetine: mechanism of action at the lower urinary tract and Onuf's nucleus.
    Jost W; Marsalek P
    Clin Auton Res; 2004 Aug; 14(4):220-7. PubMed ID: 15316838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Duloxetine: a balanced and selective norepinephrine- and serotonin-reuptake inhibitor.
    Westanmo AD; Gayken J; Haight R
    Am J Health Syst Pharm; 2005 Dec; 62(23):2481-90. PubMed ID: 16303903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update on duloxetine for the management of stress urinary incontinence.
    Basu M; Duckett JR
    Clin Interv Aging; 2009; 4():25-30. PubMed ID: 19503763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serotonin and noradrenaline reuptake inhibitors (SNRI) for stress urinary incontinence in adults.
    Mariappan P; Ballantyne Z; N'Dow JM; Alhasso AA
    Cochrane Database Syst Rev; 2005 Jul; (3):CD004742. PubMed ID: 16034945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Duloxetine receives positive recommendation by the Scientific Committee of EMEA for treatment of depression].
    Krankenpfl J; 2004; 42(7-10):247. PubMed ID: 15675409
    [No Abstract]   [Full Text] [Related]  

  • 9. An evaluation of the cardiovascular safety profile of duloxetine: findings from 42 placebo-controlled studies.
    Wernicke J; Lledó A; Raskin J; Kajdasz DK; Wang F
    Drug Saf; 2007; 30(5):437-55. PubMed ID: 17472422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and adverse event profile of duloxetine.
    Wernicke JF; Gahimer J; Yalcin I; Wulster-Radcliffe M; Viktrup L
    Expert Opin Drug Saf; 2005 Nov; 4(6):987-93. PubMed ID: 16255658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotonin and norepinephrine involvement in efferent pathways to the urethral rhabdosphincter: implications for treating stress urinary incontinence.
    Thor KB
    Urology; 2003 Oct; 62(4 Suppl 1):3-9. PubMed ID: 14550831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Duloxetine in the treatment of major psychiatric and neuropathic disorders.
    Müller N; Schennach R; Riedel M; Möller HJ
    Expert Rev Neurother; 2008 Apr; 8(4):527-36. PubMed ID: 18416656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of serotonin and noradrenaline in stress urinary incontinence.
    Michel MC; Peters SL
    BJU Int; 2004 Jul; 94 Suppl 1():23-30. PubMed ID: 15139860
    [No Abstract]   [Full Text] [Related]  

  • 14. The treatment of urinary incontinence with Duloxetine.
    Basu M; Duckett J
    J Obstet Gynaecol; 2008 Feb; 28(2):166-9. PubMed ID: 18393011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Duloxetine, a serotonin and noradrenaline reuptake inhibitor (SNRI) for the treatment of stress urinary incontinence: a systematic review.
    Mariappan P; Alhasso A; Ballantyne Z; Grant A; N'Dow J
    Eur Urol; 2007 Jan; 51(1):67-74. PubMed ID: 17014950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Place of duloxetine in the treatment of stress urinary incontinence].
    Rouprêt M; Richard F; Chartier-Kastler E
    Prog Urol; 2005 Sep; 15(4):689-92. PubMed ID: 16459687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacotherapy of stress incontinence].
    Jost WH; Marsalek P; Michel MC
    Dtsch Med Wochenschr; 2005 Oct; 130(41):2337-42. PubMed ID: 16231235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacotherapy for stress urinary incontinence.
    Castro-Diaz D; Amoros MA
    Curr Opin Urol; 2005 Jul; 15(4):227-30. PubMed ID: 15928510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain.
    Wernicke JF; Pritchett YL; D'Souza DN; Waninger A; Tran P; Iyengar S; Raskin J
    Neurology; 2006 Oct; 67(8):1411-20. PubMed ID: 17060567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Duloxetine: a new serotonin/noradrenaline reuptake inhibitor for the treatment of depression.
    Rabasseda X
    Drugs Today (Barc); 2004 Sep; 40(9):773-90. PubMed ID: 15538550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.